Outcomes of seizures, status epilepticus, and EEG findings in critically ill patient with COVID-19

被引:0
作者
Clary, Heidi M. Munger [1 ]
Wan, Mingyu [2 ]
Conner, Kelly [1 ]
Brenes, Gretchen A. [3 ]
Kimball, James [4 ]
Kim, Esther [1 ]
Duncan, Pamela [1 ]
Snively, Beverly M. [5 ]
机构
[1] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA
[2] Wake Forest Univ, Neurosci Grad Program, Winston Salem, NC 27101 USA
[3] Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Dept Internal Med, Winston Salem, NC 27101 USA
[4] Wake Forest Sch Med, Dept Psychiat, Winston Salem, NC 27101 USA
[5] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27101 USA
关键词
COVID-19; Coronavirus; SARs-CoV-2; EEG; Functional outcomes; Seizure; GENERALIZED ANXIETY DISORDER; MAJOR DEPRESSION; SCREENING TOOLS; RAPID DETECTION; EPILEPSY; INSTRUMENTS;
D O I
暂无
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has a myriad of neurological manifestations and its effects on the nervous system are increasingly recognized. Seizures and status epilepticus (SE) are reported in the novel coronavirus disease (COVID-19), both new onset and worsening of existing epilepsy; however, the exact prevalence is still unknown. The primary aim of this study was to correlate the presence of seizures, status epilepticus, and specific critical care EEG patterns with patient functional outcomes in those with COVID-19. Methods: This is a retrospective, multicenter cohort of COVID-19-positive patients in Southeast Michigan who underwent electroencephalography (EEG) from March 12th through May 15th, 2020. All patients had confirmed nasopharyngeal PCR for COVID-19. EEG patterns were characterized per 2012 ACNS critical care EEG terminology. Clinical and demographic variables were collected by medical chart review. Outcomes were divided into recovered, recovered with disability, or deceased. Results: Out of the total of 4100 patients hospitalized with COVID-19, 110 patients (2.68%) had EEG during their hospitalization; 64% were male, 67% were African American with mean age of 63 years (range 20-87). The majority (70%) had severe COVID-19, were intubated, or had multi-organ failure. The median length of hospitalization was 26.5 days (IQR = 15 to 44 days). During hospitalization, of the patients who had EEG, 21.8% had new-onset seizure including 7% with status epilepticus, majority (87.5%) with no prior epilepsy. Forty-nine (45%) patients died in the hospital, 46 (42%) recovered but maintained a disability and 15 (14%) recovered without a disability. The EEG findings associated with outcomes were background slowing/attenuation (recovered 60% vs recovered/disabled 96% vs died 96%, p < 0.001) and normal (recovered 27% vs recovered/disabled 0% vs died 1%, p < 0.001). However, these findings were no longer significant after adjusting for severity of COVID-19. Conclusion: In this large multicenter study from Southeast Michigan, one of the early COVID-19 epicenters in the US, none of the EEG findings were significantly correlated with outcomes in critically ill COVID-19 patients. Although seizures and status epilepticus could be encountered in COVID-19, the occurrence did not correlate with the patients' functional outcome. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 20 条
[1]   Validity and Utility of the Patient Health Questionnaire (PHQ)-2 and PHQ-9 for Screening and Diagnosis of Depression in Rural Chiapas, Mexico: A Cross-Sectional Study [J].
Arrieta, Jafet ;
Aguerrebere, Mercedes ;
Raviola, Giuseppe ;
Flores, Hugo ;
Elliott, Patrick ;
Espinosa, Azucena ;
Reyes, Andrea ;
Ortiz-Panozo, Eduardo ;
Rodriguez-Gutierrez, Elena G. ;
Mukherjee, Joia ;
Palazuelos, Daniel ;
Franke, Molly F. .
JOURNAL OF CLINICAL PSYCHOLOGY, 2017, 73 (09) :1076-1090
[2]   Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic [J].
Clary, Heidi M. Munger ;
Croxton, Rachel D. ;
Allan, Jonathan ;
Lovato, James ;
Brenes, Gretchen ;
Snively, Beverly M. ;
Wan, Mingyu ;
Kimball, James ;
Wong, Matthew H. ;
O'Donovan, Cormac A. ;
Conner, Kelly ;
Jones, Victor ;
Duncan, Pamela .
EPILEPSY & BEHAVIOR, 2020, 104
[3]   Should adult neurologists play a role in the management of the most common psychiatric comorbidities? Practical considerations [J].
Clary, Heidi M. Munger ;
Salpekar, Jay A. .
EPILEPSY & BEHAVIOR, 2019, 98 :309-313
[4]   Inadequacy of the PHQ-2 Depression Screener for Identifying Suicidal Primary Care Patients [J].
Dueweke, Aubrey R. ;
Marin, Mikenna S. ;
Sparkman, David J. ;
Bridges, Ana J. .
FAMILIES SYSTEMS & HEALTH, 2018, 36 (03) :281-288
[5]   Validating screening tools for depression in epilepsy [J].
Fiest, Kirsten M. ;
Patten, Scott B. ;
Wiebe, Samuel ;
Bulloch, Andrew G. M. ;
Maxwell, Colleen J. ;
Jette, Nathalie .
EPILEPSIA, 2014, 55 (10) :1642-1650
[6]   Depression screening tools in persons with epilepsy: A systematic review of validated tools [J].
Gill, Stephanie J. ;
Lukmanji, Sara ;
Fiest, Kirsten M. ;
Patten, Scott B. ;
Wiebe, Samuel ;
Jette, Nathalie .
EPILEPSIA, 2017, 58 (05) :695-705
[7]   Rapid detection of major depression in epilepsy: a multicentre study [J].
Gilliam, FG ;
Barry, JJ ;
Hermann, BP ;
Meador, KJ ;
Vahle, V ;
Kanner, AM .
LANCET NEUROLOGY, 2006, 5 (05) :399-405
[8]   Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: a comparison of five different methods [J].
Kelly, Mark J. ;
Dunstan, Frank D. ;
Lloyd, Keith ;
Fone, David L. .
BMC PSYCHIATRY, 2008, 8 (1) :10
[9]   A CONCORDANCE CORRELATION-COEFFICIENT TO EVALUATE REPRODUCIBILITY [J].
LIN, LI .
BIOMETRICS, 1989, 45 (01) :255-268
[10]   Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy [J].
Margrove, Kerrie ;
Mensah, Seth ;
Thapar, Ajay ;
Kerr, Michael .
EPILEPSY & BEHAVIOR, 2011, 21 (04) :387-390